Jericho Oil Completes Acquisition of Working Interest in Producing Central Oklahoma Assets
Oct 05, 2017 12:00 pm UTC| Business
TULSA, Okla. and VANCOUVER, British Columbia, Oct. 05, 2017 -- Further to its news release dated Aug. 2, 2017, Jericho Oil Corporation (“Jericho”) (TSX-V:JCO) (OTC PINK:JROOF) announces that it has completed the...
Oct 05, 2017 12:00 pm UTC| Business
DURANGO, Colo., Oct. 05, 2017 -- Rocky Mountain Chocolate Factory, Inc. (Nasdaq: RMCF) (the “Company”) today reported its operating results for the three and six months ended August 31, 2017. The Company franchises and...
Oct 05, 2017 12:00 pm UTC| Business
BUFFALO, N.Y., Oct. 05, 2017 -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related...
Oct 05, 2017 12:00 pm UTC| Business
DELRAY BEACH, Fla., Oct. 05, 2017 -- PositiveID Corporation (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary will exhibit the Caregiver®...
Jacada Visual IVR Launched Into Japanese Market by Dimension Data – NTT Neomeit Partnership
Oct 05, 2017 12:00 pm UTC| Business
ATLANTA, Oct. 05, 2017 -- Jacada Ltd. (OTCQB:JCDAF), a leading global provider of customer service technology designed to simplify the interaction between businesses and their customers, announced that Jacada Visual IVR...
Integer Schedules Third Quarter 2017 Earnings Release and Conference Call for October 26, 2017
Oct 05, 2017 12:00 pm UTC| Business
FRISCO, Texas, Oct. 05, 2017 -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for third quarter 2017, after market close on Thursday, October 26,...
Selecta Biosciences Announces Upcoming Clinical and Scientific Presentations
Oct 05, 2017 12:00 pm UTC| Business
WATERTOWN, Mass., Oct. 05, 2017 -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding unwanted immune responses,...